BME255: Biotechnology and Drug Development

Recommended for students interested in careers in the biopharmaceutical industry. Focuses on recombinant DNA technology and the drug-development process, including discovery research; preclinical testing; clinical trials; and regulatory review, as well as manufacturing and production considerations. Students may not receive credit for this course and course 155 and Biology 179. (Also offered as Chemistry and Biochemistry 255. Students cannot recieve credit for both courses.) Enrollment limited to graduate students. Enrollment limited to 15. P. Berman

5 Credits

While the information on this web site is usually the most up to date, in the event of a discrepancy please contact your adviser to confirm which information is correct.